en ENGLISH
eISSN: 2300-8660
ISSN: 0031-3939
Pediatria Polska - Polish Journal of Paediatrics
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Rada naukowa Bazy indeksacyjne Kontakt Zasady publikacji prac Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
Wyszukiwanie
Zasady redakcyjne
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2023
vol. 98
 
Poleć ten artykuł:
Wyślij znajomemu
Udostępnij:
streszczenie artykułu:
Opis przypadku

Eosinophilic cystitis as a rare cause of post-renal acute kidney injury in children: a case report

Anna Kawalec
1
,
Irena Wikiera-Magott
1
,
Wojciech Apoznański
2
,
Katarzyna Rasiewicz
2
,
Wojciech Krajewski
3
,
Agnieszka Hałoń
4
,
Danuta Zwolińska
1

  1. Department of Pediatric Nephrology, Wroclaw Medical University, Wroclaw, Poland
  2. Department of Pediatric Surgery and Urology, Wroclaw Medical University, Wroclaw, Poland
  3. University Center of Excellence in Urology, Department of Minimally Invasive and Robotic Urology, Wroclaw Medical University, Wroclaw, Poland
  4. Department of Clinical and Experimental Pathology, Wroclaw Medical University, Wroclaw, Poland
Pediatr Pol 2023; 98 (4): 349-353
DOI: https://doi.org/10.5114/polp.2023.133540
Data publikacji online: 2023/12/15
Pełna treść artykułu Pobierz cytowanie
 
Metryki PlumX:


Eosinophilic cystitis (EC) is a rare inflammatory disease of unclear etiopathology and various clinical presentations. We present a case of a 10-year old boy who was referred to our center because of acute kidney injury. The imaging diagnostic showed hydronephrosis, irregular thickening and infiltration of the posterior bladder wall. During cystoscopy, no ureter orifices were identified. Based on histopathological examination of bladder biopsy specimens, EC in an acute phase was diagnosed. To our knowledge the presented case is the first where EC led to post-renal acute kidney injury requiring hemodialysis. In the article we describe the diagnostic difficulties, therapy, clinical outcomes, and patient’s follow-up.